Man Group
ENTA icon

Man Group’s Enanta Pharmaceuticals ENTA Stock Holding History

Man Group’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$496K Sell
39,234
-4,613
-11% -$61.8K ﹤0.01% 2084
2025
Q4 		$691K Buy
43,847
+3,691
+9% +$46.9K ﹤0.01% 1792
2025
Q3 		$481K Buy
+40,156
New +$321K ﹤0.01% 1862
2024
Q1 		– Sell
-42,415
Closed -$399K – 2155
2023
Q4 		$399K Buy
+42,415
New +$395K ﹤0.01% 1744
2023
Q1 		– Sell
-13,698
Closed -$637K – 2118
2022
Q4 		$637K Buy
+13,698
New +$624K ﹤0.01% 1445
2021
Q1 		– Sell
-177,288
Closed -$7.46M – 1890
2020
Q4 		$7.46M Sell
177,288
-56,532
-24% -$2.49M 0.03% 577
2020
Q3 		$10.7M Buy
233,820
+63,496
+37% +$3.08M 0.04% 447
2020
Q2 		$8.55M Sell
170,324
-26,281
-13% -$1.36M 0.04% 418
2020
Q1 		$10.1M Sell
196,605
-103,480
-34% -$5.52M 0.07% 290
2019
Q4 		$18.5M Buy
300,085
+4,131
+1% +$256K 0.06% 381
2019
Q3 		$17.8M Buy
295,954
+190,743
+181% +$14.2M 0.07% 348
2019
Q2 		$8.88M Buy
105,211
+34,100
+48% +$3.07M 0.03% 680
2019
Q1 		$6.79M Buy
71,111
+39,023
+122% +$3.5M 0.03% 754
2018
Q4 		$2.27M Sell
32,088
-36,329
-53% -$2.79M 0.01% 1159
2018
Q3 		$5.85M Sell
68,417
-59,900
-47% -$6M 0.02% 901
2018
Q2 		$14.9M Sell
128,317
-147,425
-53% -$14.7M 0.06% 388
2018
Q1 		$22.3M Buy
+275,742
New +$21.2M 0.1% 203

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group's ENTA Position: Q1 2026 in Review

Man Group reduced its Enanta Pharmaceuticals (ENTA) stake by 11% in Q1 2026, selling an estimated $61.8K and leaving 39,234 shares worth $496K. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

Man Group first reported a position in ENTA in Q1 2018 and has held it in 17 quarters since. The position peaked at $22.3M in Q1 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Man Group held 39,234 shares of Enanta Pharmaceuticals worth $496K as of Q1 2026.
  • Man Group sold 4,613 Enanta Pharmaceuticals shares in Q1 2026, an estimated $61.8K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2084 holding.
  • Man Group first reported a position in Enanta Pharmaceuticals in Q1 2018 and has held it in 17 quarters since.
  • Man Group's Enanta Pharmaceuticals position peaked at $22.3M in Q1 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.